1992
DOI: 10.1016/0026-0495(92)90198-j
|View full text |Cite
|
Sign up to set email alerts
|

The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

12
71
3
3

Year Published

1999
1999
2011
2011

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 185 publications
(89 citation statements)
references
References 50 publications
12
71
3
3
Order By: Relevance
“…Thus these binding proteins may play an important role in understanding the lower GH values observed in obese individuals (4). This notion is consistent with the observation that obesity is associated with high concentrations of GHBP (20). In normal-weight individuals, GHBP is positively correlated with body fat percentage and intra-abdominal visceral fat (14).…”
supporting
confidence: 91%
“…Thus these binding proteins may play an important role in understanding the lower GH values observed in obese individuals (4). This notion is consistent with the observation that obesity is associated with high concentrations of GHBP (20). In normal-weight individuals, GHBP is positively correlated with body fat percentage and intra-abdominal visceral fat (14).…”
supporting
confidence: 91%
“…30 GHBP is identical in structure to the extracellular domain of the GH receptor. 31,32 Low GHBP has been detected in anorexia nervosa and high GHBP is seen in obesity, 33,34 a phenomena also seen in our obese patients whose GHBP concentrations decreased with the decrease in BFM. In NSC where the effect of GH on BFM was minor, an increase in GHBP was noted.…”
Section: Discussionsupporting
confidence: 66%
“…30 In addition, a decreased binding of IGF-I to its receptor has been reported, 19 and thus obesity is characterized by increased sensitivity to GH as well as resistance to IGF-I. 29 Hypoactivity of IGF-I, as observed in patients with GH deficiency, causes metabolic alterations such as insulin resistance, hypertriglyceridemia and low HDL-cholesterol associated with accumulation of visceral adipose tissue.…”
Section: Discussionmentioning
confidence: 99%